A Double-Blind Randomized Clinical Trial of the Efficacy of IM Midazolam Versus IV Lorazepam in the Pre-Hospital Treatment of Status Epilepticus by Paramedics.
Latest Information Update: 03 Jul 2024
Price :
$35 *
At a glance
- Drugs Midazolam (Primary) ; Lorazepam
- Indications Status epilepticus
- Focus Therapeutic Use
- Acronyms RAMPART
- 26 Jun 2024 Results presented in the Crossject Media Release.
- 15 Feb 2011 Actual end date (Jan 2011) added as reported by ClinicalTrials.gov.
- 10 Feb 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.